Biomerieux SA

Common Name

Biomerieux

Country

France

Sector

Healthcare

Industry

Diagnostics & Research

Employees

14,147

Ticker

BIM

Exchange

EURONEXT

Website

www.biomerieux.com

Description

bioMérieux S.A. is a global leader in the field of in vitro diagnostics, providing essential solutions to detect and manage infectious diseases, cardiovascular emergencies, and oncology. The company's... Show more

Income Statement Balance Sheet

Financial Statements of Biomerieux

Below are the financial statements of Biomerieux, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of EUR	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Goodwill	730.4^a	698.8^a
Other intangible assets	492^a	528.6^a
Property, plant and equipment	1,525.4^a	1,357.1^a
Right-of-use assets	170.2^a	148.9^a
Non-current financial assets	195^a	219.4^a
Investments in associates	0.8^a	0.8^a
Other non-current assets	9.1^a	7.7^a
Deferred tax assets	145.9^a	92.7^a
Non-current assets	3,268.9^a	3,054^a
Inventories and work-in-progress	1,037.3^a	908.5^a
Trade receivables and assets related to contracts with customers	792.3^a	728.6^a
Other operating receivables	176^a	171.7^a
Current tax receivables	21.3^a	29.7^a
Non-operating receivables	24.5^a	14.3^a
Cash and cash equivalents	449.8^a	352.4^a
Current assets	2,501.1^a	2,205.2^a
Assets held for sale	0^a	0^a
Total assets	5,770^a	5,259.2^a
Shareholders’ equity and liabilities	—	—
Share capital	12^a	12^a
Additional paid-in capital and reserves	3,760.6^a	3,382.6^a
Net income for the year	432.2^a	357.6^a
Group equity	4,204.9^a	3,752.2^a
Minority interests	6.1^a	0^a
Equity of consolidated companies	4,211^a	3,752.2^a
Long-term borrowings and debt	349.2^a	355.4^a
Deferred tax liabilities	25.7^a	11.1^a
Provisions	49.2^a	53.3^a
Non-current liabilities	424.1^a	419.7^a
Short-term borrowings and debt	141.5^a	163.4^a
Provisions	37.3^a	41.6^a
Trade payables	272.4^a	265.1^a
Other operating payables	574.2^a	495.9^a
Current tax payables	35.4^a	52.8^a
Non-operating payables	74.1^a	68.5^a
Current liabilities	1,134.9^a	1,087.3^a
Liabilities related to assets held for sale	0^a	0^a
Total shareholders’ equity and liabilities	5,770^a	5,259.2^a

Download Data

Verified Sources Behind Biomerieux’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biomerieux’s data sources below and access millions more through our Disclosure Search.

a. Biomerieux's Universal Registration Document (URD) 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Biomerieux SA

Financial Statements of Biomerieux

Verified Sources Behind Biomerieux’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

ICON PLC

Eurofins Scientific SE

Revvity Inc

Quest Diagnostics Inc

Syngene International Ltd

Lonza Group AG